Pear Therapeutics to Become a Public Company
Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (PDTs) to…
Arboretum_JDJune 22, 2021
Navv Systems Completes Seed Financing to Accelerate Commercialization
Navv Systems, a Southeastern Michigan-based healthcare technology company focused on hospital personnel location and equipment…
Arboretum_JDJune 9, 2021
Francis Medical Announces Positive Data from VAPOR 1 IDE Study
Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor…
Arboretum_JDJune 8, 2021
EQRx Reports Positive Phase 3 Result for Sugemalimab (PD-L1 program)
EQRx, a company committed to developing and delivering important new medicines at lower prices, along…
Arboretum_JDMay 28, 2021
Koya Medical Receives FDA Clearance for Compression Therapy System
Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases…
Arboretum_JDMay 26, 2021
EQRx Announces Results of Aumolertinib’s Phase III Trial
Aumolertinib Significantly Prolongs Progression-Free Survival with Fewer Side Effects in the First-Line Treatment of Patients…
Arboretum_JDMay 20, 2021
Strata Oncology Launches Strata Assistant Epic app to Integrate Precision Oncology into Clinical Practice
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…
Arboretum_JDMay 19, 2021
ArborMetrix Announces Maria Siambekos as New CEO
ArborMetrix today announced its Board of Directors has appointed Maria Siambekos, M.B.A., as Chief Executive…
Arboretum_JDMay 11, 2021
Hicuity Health Honored with MedTech Breakthrough Award for Second Consecutive Year
Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced that the company has…
Arboretum_JDMay 6, 2021
